IN2015DN04161A - - Google Patents

Download PDF

Info

Publication number
IN2015DN04161A
IN2015DN04161A IN4161DEN2015A IN2015DN04161A IN 2015DN04161 A IN2015DN04161 A IN 2015DN04161A IN 4161DEN2015 A IN4161DEN2015 A IN 4161DEN2015A IN 2015DN04161 A IN2015DN04161 A IN 2015DN04161A
Authority
IN
India
Prior art keywords
drug
inner core
relates
present
osmotic
Prior art date
Application number
Inventor
Varinder Kumar
Shavej Ahmad
Romi Barat Singh
Ajay Kumar Singla
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN4161DEN2015 priority Critical patent/IN2015DN04161A/en
Publication of IN2015DN04161A publication Critical patent/IN2015DN04161A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an osmotic floating tablet comprising: (i) an inner core comprising a drug one or more low density polymers and one or more pharmaceutically acceptable excipients; and (ii) an outer osmotic coating surrounding the inner core that is substantially permeable to surrounding fluids and substantially impermeable to the drug. The present invention also relates to processes for the preparation of said tablets.
IN4161DEN2015 2012-10-16 2013-10-15 IN2015DN04161A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN4161DEN2015 IN2015DN04161A (en) 2012-10-16 2013-10-15

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3222DE2012 2012-10-16
PCT/IB2013/059374 WO2014060952A1 (en) 2012-10-16 2013-10-15 Osmotic floating tablets
IN4161DEN2015 IN2015DN04161A (en) 2012-10-16 2013-10-15

Publications (1)

Publication Number Publication Date
IN2015DN04161A true IN2015DN04161A (en) 2015-10-16

Family

ID=49880871

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4161DEN2015 IN2015DN04161A (en) 2012-10-16 2013-10-15

Country Status (4)

Country Link
US (1) US9861585B2 (en)
EP (1) EP2908803A1 (en)
IN (1) IN2015DN04161A (en)
WO (1) WO2014060952A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017058869A1 (en) 2015-09-29 2017-04-06 Acorda Therapeutics, Inc. Sustained release compositions of 4-aminopyridine
CN107753457A (en) * 2017-10-26 2018-03-06 青岛黄海制药有限责任公司 A kind of nifedipine micropore permeation pump clad sheet with expansion label and preparation method thereof
CN107961225A (en) * 2017-12-07 2018-04-27 中国药科大学 A kind of Pregabalin micro hole seep irrigation and preparation method thereof
US11147767B2 (en) * 2019-02-25 2021-10-19 Rubicon Research Private Limited Gastroretentive formulations
CN109966258A (en) * 2019-04-26 2019-07-05 安阳天助药业有限责任公司 A kind of coating pre-mixing agent for preventing coloured tablet from fading
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
DK3760190T3 (en) 2019-07-03 2023-09-04 Alvogen Inc TABLETS OF PREGABALIN WITH EXTENDED RELEASE, METHOD OF MANUFACTURE AND METHOD OF USING THEREOF
CN112137984B (en) * 2020-10-30 2023-02-03 四川制药制剂有限公司 Cefaclor capsule and preparation process thereof
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU213407B (en) 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
US7029701B2 (en) * 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US20030175349A1 (en) 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20050031688A1 (en) * 2003-08-04 2005-02-10 Ayala William J. Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
NL2000281C2 (en) 2005-11-02 2007-08-07 Pfizer Prod Inc Solid pharmaceutical compositions containing pregabalin.
WO2007078895A2 (en) 2005-12-30 2007-07-12 Biovail Laboratories International S.R.L. Modified release formulations of tramadol and uses thereof
CA2655596C (en) 2006-06-27 2011-10-25 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
US8454993B2 (en) 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
US20120208773A1 (en) * 2008-08-12 2012-08-16 Valeant International (Barbados) Srl Pharmaceutical compositions with tetrabenazine
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
RU2012100709A (en) 2009-06-12 2013-07-20 Майкро Лэбз Лимитед NEW PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN
IN2012MN02923A (en) 2010-06-01 2015-06-05 Rubicon Res Private Ltd

Also Published As

Publication number Publication date
WO2014060952A1 (en) 2014-04-24
US9861585B2 (en) 2018-01-09
US20150231084A1 (en) 2015-08-20
EP2908803A1 (en) 2015-08-26

Similar Documents

Publication Publication Date Title
IN2015DN04161A (en)
CO2017012362A2 (en) Solid dosage forms comprising palbociclib, a water-soluble acid and a pharmaceutically acceptable carrier and methods for their production and use
PH12016500121A1 (en) Pharmaceutical tablet comprising acetylsalicyclic acid and clopidogrel
MX350875B (en) Controlled release pharmaceutical dosage forms.
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
TW201711676A (en) Ferric citrate dosage forms
WO2014114255A3 (en) Positioning, quick-release bioadhesion agent and use
MX2015005534A (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
IN2014DN06966A (en)
CL2012003523A1 (en) Method for the preparation of a pharmaceutical composition containing a thermostable oxygen carrier; pharmaceutical composition containing a highly purified and thermostable oxygen carrier.
MX340188B (en) Manufacturing of active-free granules and tablets comprising the same.
HUE060093T2 (en) Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
MX2022015606A (en) Immediate-release tablets containing a drug and processes for forming the tablets.
PH12014501408A1 (en) Immediate release multi unit pellet system
TN2012000507A1 (en) Enteric tablet
IN2014DN06965A (en)
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
PH12014502325B1 (en) Sustained release tablet containing levodropropizine and method for preparing same
EA201891886A1 (en) CONTAINING PREGABALIN A THREE-LAYER TABLET WITH SLOW-RELEASE EXTRACTION FOR ORAL RECEPTION
IN2013MU01111A (en)
RS20130034A1 (en) Pharmaceutical mixture for the prolonged release of trimetazidine
HK1220113A1 (en) Pharmaceutical soft gelatin capsule dosage form
EA201270269A1 (en) PHARMACEUTICAL TABLET CONTAINING ROSUVASTATIN CALCIUM
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form